Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,729 evidence items · page 17 / 70

11 %Key populations account for 11% of new HIV infections in Nigeria.

NigeriaVIH/sidapublished 2025AIDS research and therapyPubMeddocument of 4 observations

15,000 peopleTreatment of people living with HIV in Nigeria commenced in 2002 and increased from about 15,000 to more than 1,780,000 people living with HIV in 2023.

NigeriaVIH/sidaobserved 2002published 2025AIDS research and therapyPubMeddocument of 4 observations

59.4 %Somatic and psychological challenges among women living with HIV included joint/muscle complaints at a rate of 59.4%, sleeping disorders at 29.2%, anxiety at 27.4%, depression at 26.5%, irritability at 23.5%, and exhaustion at 22.3%.

NigeriaVIH/sidapublished 2025West African journal of medicinePubMeddocument of 10 observations

53 %Overall quality of life was significantly worse among women with HIV than HIV-negative women, with 53% versus 63% reporting good quality of life.

NigeriaVIH/sidaobserved 2024published 2026AIDS carePubMeddocument of 4 observations

0.4 %Mixed infections of two or more Candida species occurred in 0.4% of the patients.

Nigeriaoral candidiasis · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 11 observations

36 %At baseline, 36% of the respondents in the control group had good knowledge of HIV/AIDS.

NigeriaVIH/sidapublished 2024BMC public healthPubMeddocument of 5 observations

27.8 %The uptake of HIV testing was low among senior secondary school students in Lagos, Nigeria, at 27.8% for males and 24.1% for females.

NigeriaVIH/sidapublished 2019West African journal of medicinePubMeddocument of 7 observations

13 %Among clinical students in northern Nigeria who reported accidental exposure to HIV, only 13% received post-exposure prophylaxis (PEP).

NigeriaVIH/sidapublished 2020The international journal of occupational and environmental medicinePubMeddocument of 5 observations

34 %Among long-distance truck drivers in Ekiti State, Nigeria, 34.0% patronised commercial sex workers in the past 6 months.

NigeriaVIH/sidaobserved 2019published 2021The Nigerian postgraduate medical journalPubMeddocument of 7 observations

2,139 patientsAmong patients enrolled on antiretroviral therapy from 2004 to 2017, 2,139 (0.9%) self-terminated treatment.

NigeriaVIH/sidaobserved 2004 to 2017published 2019AIDS research and therapyPubMeddocument of 11 observations

0.001 p-valueThe difference in mean BMI Z-scores between perinatally HIV-infected males on HAART and HIV-negative controls was statistically significant (p < 0.001).

NigeriaVIH/sidapublished 2022BMC pediatricsPubMeddocument of 6 observations

3.1 %The prevalence of HIV among female adolescents aged 10 to 19 years seeking healthcare services at the Federal Teaching Hospital, Birnin Kebbi, Nigeria, was 3.1% between January and June 2023.

NigeriaVIH/sidaobserved January and June 2023published 2025African journal of reproductive healthPubMeddocument of 4 observations

38.5 %Of 387 participants with CD4 data, 149 (38.5%) had severe immunodeficiency (<200 cells/μL).

NigeriaVIH/sidaobserved 2019–2021published 2026Frontiers in public healthPubMeddocument of 7 observations

25.8 %The prevalence of anaemia was 25.8% among patients co-infected with malaria and HIV.

Nigeriaanémie · paludisme · VIH/sidapublished 2013African health scienceseurope_pmcdocument of 5 observations

91.16 %Of 13,286 HIV tests completed for people who inject drugs from January 2020 to September 2021, 12,111 (91.16%) had negative results.

NigeriaVIH/sidaobserved January 2020 to September 2021published 2023Global health, science and practicePubMeddocument of 7 observations

55 %Fifty-five percent of youth with HIV in Nigeria were perinatally infected in a single-arm trial.

NigeriaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations

75.4 %Among HIV-positive pregnant women in Kaduna State, 75.4% had good knowledge of HIV.

NigeriaVIH/sidapublished 2025Scientific reportsPubMeddocument of 4 observations

2.27 risk_ratioBeing prescribed antiretroviral therapy was associated with HIV status disclosure to female sexual partners (RR 2.27 [95% CI 1.07–4.83]).

NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 6 observations

15.54 %The prevalence of poor virological outcome was 15.54% among HIV-infected individuals on HAART in three treatment facilities in Osogbo, Southwest Nigeria.

NigeriaVIH/sidapublished 2025BMC infectious diseasesPubMeddocument of 2 observations

23 casesRefractive error was the most common cause of moderate visual impairment in 23 (20%) cases.

Nigeriarefractive error · VIH/sidapublished 2023West African journal of medicinePubMeddocument of 9 observations

47.6 %HIV prevalence among non-binary/other individuals in Abuja and Lagos, Nigeria was 47.6%.

NigeriaVIH/sidaobserved 2013 to 2020published 2022Journal of the International AIDS SocietyPubMeddocument of 20 observations

0.333 fractionA third of new human immunodeficiency virus (HIV) infections occur among young people.

NigeriaVIH/sidapublished 2021The patientPubMeddocument of 6 observations

3.45 %Among young adults (20–24 years) living with HIV in Nigeria, facility characteristics accounted for 3.45% of the variance in viral suppression.

NigeriaVIH/sidapublished 2020BMJ global healthPubMeddocument of 7 observations

66 %Sub-Saharan Africa is home to approximately 66% of all people living with HIV globally.

NigeriaVIH/sidapublished 2025International journal of adolescent medicine and healthPubMeddocument of 6 observations

16.2 odds_ratioBeing an HIV-infected person on first-line cART was associated with malaria antigenaemia (OR = 16.20, p = 0.04).

Nigeriapaludisme · VIH/sidaobserved 2018–2019published 2024BMC infectious diseasesPubMeddocument of 15 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.